151910 — SBW Life Sciences Co Share Price
- KR₩122bn
- KR₩132bn
- KR₩48bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.42 | ||
Price to Tang. Book | 3.6 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.52 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -12.53% | ||
Return on Equity | -20.73% | ||
Operating Margin | -10.24% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 52,623.03 | 56,967.08 | 51,482.02 | 50,851.63 | 48,310.29 | n/a | n/a | -4.59% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
SBW Life Sciences Co Ltd, formerly Nanos Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of optical filters. The Company main products include blue filters, film filters, infrared (IR) cut-off filters, IR pass filters, IR band pass filters, two band pass filters and others. In addition, the Company is engaged in the manufacture and sale of hall sensors.
Directors
- Jong Beom Kim CEO (59)
- Won Jin Cho VPR (54)
- Yeong Dae Gong MDR (50)
- Mun Su Kim OTH (52)
- Yong Ju Park OTH (52)
- Jong Hwa Lee OTH (43)
- Jae Yong Shin OTH (62)
- Sang Jin Lee DRC (48)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 2nd, 2004
- Public Since
- August 2nd, 2012
- No. of Shareholders
- 14,685
- No. of Employees
- 449
- Sector
- Electronic Equipments & Parts
- Industry
- Technology
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 190,071,722
- Address
- 4, Madogongdan-ro 2-gil, SUWON, 16675
- Web
- http://sbw-lfs.com/
- Phone
- +82 312403900
- Auditors
- Sahmhwa Accounting Corp.
Upcoming Events for 151910
Q2 2024 SBW Life Sciences Co Ltd Earnings Release
Similar to 151910
ABCO Electronics Co
Korea Exchange - KOSDAQ
Actro Co
Korea Exchange - KOSDAQ
Ajinextek Co
Korea Exchange - KOSDAQ
Amogreentech Co
Korea Exchange - KOSDAQ
Amotech Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:19 UTC, shares in SBW Life Sciences Co are trading at KR₩640. This share price information is delayed by 15 minutes.
Shares in SBW Life Sciences Co last closed at KR₩640 and the price had moved by +0.47% over the past 365 days. In terms of relative price strength the SBW Life Sciences Co share price has outperformed the FTSE Developed Asia Pacific Index by +1.17% over the past year.
There is no consensus recommendation for this security.
SBW Life Sciences Co does not currently pay a dividend.
SBW Life Sciences Co does not currently pay a dividend.
SBW Life Sciences Co does not currently pay a dividend.
To buy shares in SBW Life Sciences Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩640, shares in SBW Life Sciences Co had a market capitalisation of KR₩122bn.
Here are the trading details for SBW Life Sciences Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 151910
Based on an overall assessment of its quality, value and momentum SBW Life Sciences Co is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SBW Life Sciences Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +24.8%.
As of the last closing price of KR₩640, shares in SBW Life Sciences Co were trading +36.46% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SBW Life Sciences Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩640.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SBW Life Sciences Co's management team is headed by:
- Jong Beom Kim - CEO
- Won Jin Cho - VPR
- Yeong Dae Gong - MDR
- Mun Su Kim - OTH
- Yong Ju Park - OTH
- Jong Hwa Lee - OTH
- Jae Yong Shin - OTH
- Sang Jin Lee - DRC